General Information of Drug Off-Target (DOT) (ID: OTHUWQHP)

DOT Name OTU domain-containing protein 3 (OTUD3)
Synonyms EC 3.4.19.12
Gene Name OTUD3
Related Disease
Breast cancer ( )
Breast carcinoma ( )
Colon cancer ( )
Colon carcinoma ( )
Lung adenocarcinoma ( )
Lung cancer ( )
Lung carcinoma ( )
Multiple sclerosis ( )
Non-small-cell lung cancer ( )
Ulcerative colitis ( )
UniProt ID
OTUD3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
4BOU
EC Number
3.4.19.12
Pfam ID
PF02338
Sequence
MSRKQAAKSRPGSGSRKAEAERKRDERAARRALAKERRNRPESGGGGGCEEEFVSFANQL
QALGLKLREVPGDGNCLFRALGDQLEGHSRNHLKHRQETVDYMIKQREDFEPFVEDDIPF
EKHVASLAKPGTFAGNDAIVAFARNHQLNVVIHQLNAPLWQIRGTEKSSVRELHIAYRYG
EHYDSVRRINDNSEAPAHLQTDFQMLHQDESNKREKIKTKGMDSEDDLRDEVEDAVQKVC
NATGCSDFNLIVQNLEAENYNIESAIIAVLRMNQGKRNNAEENLEPSGRVLKQCGPLWEE
GGSGARIFGNQGLNEGRTENNKAQASPSEENKANKNQLAKVTNKQRREQQWMEKKKRQEE
RHRHKALESRGSHRDNNRSEAEANTQVTLVKTFAALNI
Function
Deubiquitinating enzyme that hydrolyzes 'Lys-6'- and 'Lys-11'-linked polyubiquitin. Also hydrolyzes heterotypic (mixed and branched) and homotypic chains. Important regulator of energy metabolism. Glucose and fatty acids trigger its nuclear translocation by CBP-dependent acetylation. In the nucleus, deubiquitinates and stabilizes the nuclear receptor PPARD regulating the expression of various genes involved in glucose and lipid metabolism and oxidative phosphorylation. Also acts as a negative regulator of the ribosome quality control (RQC) by mediating deubiquitination of 40S ribosomal proteins RPS10/eS10 and RPS20/uS10, thereby antagonizing ZNF598-mediated 40S ubiquitination.
Reactome Pathway
Regulation of PTEN stability and activity (R-HSA-8948751 )
Ovarian tumor domain proteases (R-HSA-5689896 )

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast cancer DIS7DPX1 Strong Genetic Variation [1]
Breast carcinoma DIS2UE88 Strong Genetic Variation [1]
Colon cancer DISVC52G Strong Biomarker [2]
Colon carcinoma DISJYKUO Strong Biomarker [2]
Lung adenocarcinoma DISD51WR Strong Genetic Variation [1]
Lung cancer DISCM4YA Strong Biomarker [1]
Lung carcinoma DISTR26C Strong Biomarker [1]
Multiple sclerosis DISB2WZI Strong Genetic Variation [3]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [4]
Ulcerative colitis DIS8K27O Limited Genetic Variation [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of OTU domain-containing protein 3 (OTUD3). [6]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of OTU domain-containing protein 3 (OTUD3). [7]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of OTU domain-containing protein 3 (OTUD3). [8]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of OTU domain-containing protein 3 (OTUD3). [9]
methyl p-hydroxybenzoate DMO58UW Investigative methyl p-hydroxybenzoate increases the expression of OTU domain-containing protein 3 (OTUD3). [10]
------------------------------------------------------------------------------------

References

1 The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.Nat Commun. 2019 Jul 2;10(1):2914. doi: 10.1038/s41467-019-10824-7.
2 MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.J Cell Biochem. 2019 Nov;120(11):18629-18639. doi: 10.1002/jcb.28874. Epub 2019 Jul 24.
3 Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.Ann Neurol. 2011 Dec;70(6):897-912. doi: 10.1002/ana.22609.
4 Distinct expression and prognostic value of OTU domain-containing proteins in non-small-cell lung cancer.Oncol Lett. 2019 Nov;18(5):5417-5427. doi: 10.3892/ol.2019.10883. Epub 2019 Sep 19.
5 Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL).Nat Genet. 2010 Apr;42(4):292-4. doi: 10.1038/ng.553. Epub 2010 Mar 14.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
8 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
9 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
10 Transcriptome dynamics of alternative splicing events revealed early phase of apoptosis induced by methylparaben in H1299 human lung carcinoma cells. Arch Toxicol. 2020 Jan;94(1):127-140. doi: 10.1007/s00204-019-02629-w. Epub 2019 Nov 20.